Corona Remedies Ltd.

CORONA Remedies acquires Wokadine brand in India from Dr Reddy''s Laboratories. Expands product portfolio & market penetration.

Novartis India stock jumps 20% after Novartis AG sells stake to ChrysCapital. Open offer for public shareholders announced.

Gujarat business leaders welcome Union Budget, citing growth focus, fiscal discipline, and support for key sectors like manufacturing.

Corona Remedies shares soared over 35% on their market debut. IPO subscribed 137 times. Company valuation at Rs 8,789.93 crore.

Corona Remedies shares debut with a 38% premium. IPO subscribed 137 times. Market valuation at Rs 8,996.65 crore. Details here.

RBI increases threshold for lower risk weights on individual exposures to Rs 10 crore. Basel III norms revised for credit risk.

NSE''s registered investor base surpasses 13 crore, driven by retail participation and digital access. Growth, demographics, and market trends.

Coal India reports 11.1% rise in Q4 net profit to Rs 10,839.18 crore, driven by higher revenue. Dividend declared at Rs 5.25 per share.

Report says India's inbound tourism is below potential despite diverse offerings. Focus on experience-led travel, branding, & tech.

Report reveals mismatch between UG students' salary expectations (Rs 5 LPA) and actual achievement (40%). Skills & AI readiness are key.

MEA clarifies differences at recent BRICS meeting in Delhi were due to the ongoing conflict in West Asia. India''s position on Palestine remains unchanged.

Piyush Goyal meets exporters to discuss ways to increase India's shipments, leverage FTAs, and address global uncertainties.

RBI increases threshold for lower risk weights on individual exposures to Rs 10 crore. Basel III norms revised for credit risk.

Punjab explores natural gas & oil reserves after potash discovery. Seismic surveys planned to boost energy sector & economic growth.

Himachal Pradesh urges Centre to revise cost norms & extend timelines for water & irrigation projects due to terrain & rising costs.